Skip menu navigation Home > PTMD Home > PTMD Listing of Viewable Reports > Table of Contents for This Set of Reports


U.S. PATENT AND TRADEMARK OFFICE
Office of Electronic Information Products
Patent Technology Monitoring Division (PTMD)

Patenting In Technology Classes,
Breakout By Organization

Count of 1998 - 2002 Utility Patent Grants,
By Calendar Year of Grant
With Patent Counts Based on Primary Patent Classification

- Explanation of Data -

Rank Ordered Listing of Organizations Receiving 5 or More Utility Patents During the Period
Having Primary Classification In

Class 530, Chemistry: Natural Resins or Derivatives; Peptides or Proteins; Lignins or Reaction Products Thereof

( technology class is determined by the primary classification assigned to the patent- see 'Explanation of Data' )
( patent ownership is determined by the first-named assignee listed on a patent )

The following table displays first-named assignees and counts of their associated patents, as distributed by the year of patent grant
First-Named Assignee 1998 1999 2000 2001 2002 Total
~Individually Owned Patent 45 38 18 40 30 171
GENENTECH, INC. 20 14 21 11 15 81
UNIVERSITY OF CALIFORNIA, THE REGENTS OF 14 12 19 14 9 68
SMITHKLINE BEECHAM CORPORATION 2 8 15 22 17 64
UNITED STATES OF AMERICA, HEALTH & HUMAN SERVICES 14 12 7 7 6 46
INCYTE PHARMACEUTICALS, INC. 7 15 14 4 0 40
LUDWIG INSTITUTE FOR CANCER RESEARCH 4 8 11 6 9 38
HUMAN GENOME SCIENCES, INC. 1 10 6 5 15 37
CHIRON CORPORATION 11 9 7 3 4 34
JOHNS HOPKINS UNIVERSITY 8 10 7 7 2 34
ZYMOGENETICS, INC. 2 8 3 9 11 33
AMGEN 4 8 8 8 4 32
BAYER CORPORATION 7 7 5 7 5 31
MILLENNIUM PHARMACEUTICALS, INC. 1 1 12 6 10 30
THE SCRIPPS RESEARCH INSTITUTE 8 5 5 8 4 30
IMMUNEX CORPORATION 5 7 4 5 5 26
GENERAL HOSPITAL CORPORATION 8 8 4 1 4 25
MERCK + CO., INC. 5 6 2 6 6 25
BRISTOL-MYERS SQUIBB COMPANY 8 8 2 2 4 24
ROCKEFELLER UNIVERSITY 5 4 7 4 4 24
INCYTE GENOMICS, INC. 0 0 1 11 11 23
SALK INSTITUTE FOR BIOLOGICAL STUDIES 9 4 2 6 2 23
SCHERING CORP. 4 4 2 7 5 22
NOVO NORDISK A/S 2 5 4 4 6 21
GENETICS INSTITUTE, INC. 5 5 2 5 3 20
HOFFMANN-LA ROCHE INC. 9 4 3 2 2 20
LA JOLLA CANCER RESEARCH FOUNDATION 8 5 2 2 2 19
ICOS CORPORATION OF AMERICA 7 6 1 2 1 17
WASHINGTON UNIVERSITY 2 6 3 5 1 17
TAKEDA CHEMICAL INDUSTRIES LTD. 1 5 4 4 2 16
DANA-FARBER CANCER INSTITUTE, INC. 3 2 3 3 4 15
ELI LILLY AND COMPANY 5 3 4 1 2 15
STANFORD UNIVERSITY, LELAND JUNIOR, THE BOARD OF TRUSTEES OF 3 1 2 5 4 15
ABBOTT LABORATORIES 3 2 4 4 1 14
HARVARD COLLEGE, PRESIDENT AND FELLOWS 4 3 3 1 3 14
UNIVERSITY OF TEXAS 2 1 5 5 1 14
BASF AKTIENGESELLSCHAFT 3 4 1 5 0 13
KYOWA HAKKO KOGYO CO., LTD 3 4 1 3 2 13
THOMAS JEFFERSON UNIVERSITY 0 2 1 4 6 13
UNIVERSITY OF MINNESOTA, THE REGENTS OF 4 4 1 2 2 13
UNIVERSITY OF UTAH RESEARCH FOUNDATION 4 2 1 3 3 13
CONNAUGHT LABORATORIES LIMITED 3 3 4 2 0 12
CORVAS INTERNATIONAL, INC. 4 4 3 0 1 12
UNIVERSITY OF PENNSYLVANIA 2 4 1 3 2 12
UNIVERSITY OF WASHINGTON 3 3 3 2 1 12
BRIGHAM AND WOMEN'S HOSPITAL 5 0 3 2 1 11
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2 3 0 2 4 11
NEW YORK UNIVERSITY 5 2 1 0 3 11
PHARMACIA & UPJOHN AB 5 3 3 0 0 11
YALE UNIVERSITY 4 3 2 1 1 11
YEDA RESEARCH AND DEVELOPMENT CO., LTD. 0 3 2 2 4 11
AFFYMAX TECHNOLOGIES N.V. 6 3 0 1 0 10
CORNELL RESEARCH FOUNDATION INC. 3 3 1 2 1 10
DADE BEHRING MARBURG GMBH 0 2 2 3 3 10
WISCONSIN ALUMNI RESEARCH FOUNDATION 1 3 2 3 1 10
BAYER AKTIENGESELLSCHAFT 2 2 1 2 2 9
COLUMBIA UNIVERSITY 1 3 0 4 1 9
ROCHE DIAGNOSTICS GMBH 0 3 0 2 4 9
AKZO NOBEL NV 0 2 2 0 4 8
AMERICAN CYANAMID COMPANY 3 4 0 0 1 8
BIOPURE CORPORATION 2 4 1 1 0 8
CHUGAI SEIYAKU KABUSHIKI KAISHA 2 1 1 4 0 8
COR THERAPEUTICS, INC. 5 2 1 0 0 8
CORIXA CORPORATION 3 0 2 2 1 8
ENZON, INC. 1 4 1 2 0 8
MERCK FROSST CANADA, INC. 4 0 2 1 1 8
MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG 2 4 0 0 2 8
NOVARTIS CORPORATION 2 2 3 1 0 8
PIONEER HI-BRED INTERNATIONAL, INC. 3 1 0 1 3 8
PROLINX, INC. 1 3 2 0 2 8
TULARIK INC. 2 1 1 4 0 8
VIRGINIA COMMONWEALTH UNIVERSITY 1 4 3 0 0 8
ALPHA THERAPEUTIC CORPORATION 2 1 2 1 1 7
APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. 1 2 0 0 4 7
ARCH DEVELOPMENT CORP. 2 0 2 1 2 7
BAXTER BIOTECH TECHNOLOGY SARL 0 2 2 2 1 7
BAXTER INTERNATIONAL INC. 4 2 1 0 0 7
BAYLOR COLLEGE OF MEDICINE 1 1 2 2 1 7
BIOMEASURE, INC. 3 2 0 2 0 7
CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED 0 2 1 2 2 7
COLD SPRING HARBOR LABORATORY 1 3 1 1 1 7
DUKE UNIVERSITY INC. 1 2 3 0 1 7
HESKA CORPORATION 0 1 2 0 4 7
IMMUNO AKTIENGESELLSCHAFT 2 5 0 0 0 7
INSTITUT PASTEUR 4 3 0 0 0 7
ISIS PHARMACEUTICALS, INC. 1 3 0 0 3 7
OREGON HEALTH SCIENCES UNIVERSITY 3 2 1 0 1 7
PROTEIN POLYMER TECHNOLOGIES, INC. 3 0 2 1 1 7
SMITHKLINE BEECHAM PLC 0 0 0 3 4 7
ST. JUDE CHILDREN'S RESEARCH HOSPITAL 0 1 2 2 2 7
TANOX BIOSYSTEMS, INC. 3 1 1 1 1 7
UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 1 2 0 2 2 7
UNIVERSITY OF MICHIGAN 0 3 3 0 1 7
UNIVERSITY OF NORTH CAROLINA 3 1 2 1 0 7
XOMA CORPORATION 3 2 1 0 1 7
BETH ISRAEL DEACONESS MEDICAL CENTER, INC. 1 2 1 2 0 6
BIOGEN, INC. 2 0 0 3 1 6
CALIFORNIA INSTITUTE OF TECHNOLOGY, INC. 3 1 1 1 0 6
CELLTECH THERAPEUTICS LIMITED 0 5 0 0 1 6
EASTMAN KODAK COMPANY 1 2 3 0 0 6
HOECHST AKTIENGESELLSCHAFT 1 2 3 0 0 6
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 1 3 1 1 0 6
JURIDICAL FOUNDATION, THE CHEMO-SERO-THERAPEUTIC RESEARCH IN 3 0 1 0 2 6
MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. 0 1 0 5 0 6
MEDICAL RESEARCH COUNCIL 0 3 1 1 1 6
MERRELL PHARMACEUTICALS INC. 2 3 1 0 0 6
MITSUBISHI CHEMICAL CORPORATION 3 1 0 1 1 6
PROGENICS PHARMACEUTICALS, INC. 1 1 1 1 2 6
REGENERON PHARMACEUTICALS, INC. 1 1 1 1 2 6
RHONE-POULENC RORER, S.A. 3 3 0 0 0 6
TRIMERIS, INC. 0 0 2 2 2 6
UNITED STATES OF AMERICA, ARMY 1 2 1 1 1 6
UNITED STATES OF AMERICA, DEPARTMENT OF AGRICULTURE 1 1 2 0 2 6
UNIVERSITY OF BRITISH COLUMBIA 0 1 0 4 1 6
UNIVERSITY OF MARYLAND 1 4 0 0 1 6
WASHINGTON RESEARCH FOUNDATION 2 1 2 1 0 6
ZENECA LIMITED 3 1 0 1 1 6
AJINOMOTO COMPANY INCORPORATED 2 2 1 0 0 5
ALLELIX BIOPHARMACEUTICALS INC. 2 1 2 0 0 5
BEHRINGWERKE AKTIENGESELLSCHAFT 1 3 1 0 0 5
BOEHRINGER MANNHEIM G.M.B.H. 3 1 1 0 0 5
CHILDREN'S MEDICAL CENTER CORPORATION 1 1 1 2 0 5
FRED HUTCHINSON CANCER RESEARCH CENTER 2 0 0 2 1 5
FUJISAWA PHARMACEUTICAL CO., LTD. 0 1 1 2 1 5
G. D. SEARLE & CO. 3 2 0 0 0 5
HAYASHIBARA BIOCHEMICAL LABORATORIES INCORPORATED 0 1 0 2 2 5
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V 1 2 0 0 2 5
MONSANTO COMPANY, INC. 1 1 2 1 0 5
MYCOGEN CORPORATION 3 1 1 0 0 5
N. V. INNOGENETICS S.A. 0 0 0 3 2 5
NEW YORK BLOOD CENTER, INC. 3 0 1 1 0 5
NOVARTIS AG (FORMERLY SANDOZ LTD.) 0 1 1 1 2 5
OKLAHOMA MEDICAL RESEARCH FOUNDATION 3 0 2 0 0 5
PHARMACIA & UPJOHN COMPANY 0 4 0 1 0 5
PROTEIN DESIGN LABS, INC. 2 0 1 1 1 5
RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK 3 0 1 1 0 5
STRYKER CORPORATION 2 0 2 0 1 5
TECNOGEN S.C.P.A. 0 2 0 2 1 5
TRIPEP AB 0 0 0 2 3 5
TULANE EDUCATIONAL FUND 3 0 1 1 0 5
UNIVERSITY OF ARKANSAS 1 2 1 0 1 5
UNIVERSITY OF NEBRASKA, THE BOARD OF REGENTS OF 1 3 0 0 1 5
VANDERBILT UNIVERSITY 1 1 2 1 0 5


PTMD Contacts

Questions regarding these reports should be directed to:

U.S. Patent and Trademark Office
Office of Electronic Information Products - PTMD
PK3- Suite 441; P.O Box 1450
Alexandria VA 22313

tel: (703) 306-2600
fax: (703) 306-2737
email: oeip@uspto.gov

address of PTMD pages at the USPTO Web Site: http://www.uspto.gov/web/offices/ac/ido/oeip/taf/tafp.html
ftp download of selected PTMD reports and materials from : ftp.uspto.gov/pub/taf/


Top

Skip menu navigation Home > PTMD Home > PTMD Listing of Viewable Reports > Table of Contents for This Set of Reports